Julius Baer launching biotech fund in UK

clock

Swiss wealth manager Julius Baer is launching its Biotech fund to UK investors.

Launched on 31 January 2008, the Julius Baer Biotech fund's euro share class returned 4.75% in its first full year. The fund focuses on companies which develop products and technology for four sectors - healthcare, agricultural, food science and environmental. Managed by Eric Bernhardt and Nathalie Flury, the fund plays on the fact investment in biotech in the US - where this fund focus most of its portfolio - trebled between 1996 and 2008. Biotech beat the broader indices in 2008 - the S&P500 lost around 40% over the year, while the Nasdaq Biotechnology Index declined by 12%. Bernh...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Green

CCLA on connecting returns with sustainability

CCLA on connecting returns with sustainability

‘We are about doing good but also generating returns’

Isabel Baxter
clock 17 April 2024 • 3 min read
Getting sustainability assurance is 'challenge' for advisers

Getting sustainability assurance is 'challenge' for advisers

‘It starts from the manufacturers and producers down to the advisers'

Isabel Baxter
clock 18 March 2024 • 4 min read
Sustainability Disclosure Requirements: What the regime means for IFAs

Sustainability Disclosure Requirements: What the regime means for IFAs

Sustainability claims must be fair, clear and not misleading

Julie Hardie
clock 20 February 2024 • 5 min read